Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

被引:0
|
作者
Qingzhu Jia
Wei Wu
Yuqi Wang
Peter B. Alexander
Chengdu Sun
Zhihua Gong
Jia-Nan Cheng
Huaibo Sun
Yanfang Guan
Xuefeng Xia
Ling Yang
Xin Yi
Yisong Y. Wan
Haidong Wang
Ji He
P. Andrew Futreal
Qi-Jing Li
Bo Zhu
机构
[1] Third Military Medical University,Institute of Cancer, Xinqiao Hospital
[2] Chongqing Key Laboratory of Tumor Immunotherapy,Department of Cardiothorathic Surgery, Southwest Hospital
[3] Third Military Medical University,Department of Immunology
[4] Geneplus-Beijing Institute,Biomedical Analysis Center
[5] Duke University Medical Center,Department of Microbiology and Immunology, Lineberger Comprehensive Cancer Center
[6] Third Military Medical University,Department of Genomic Medicine
[7] Houston Methodist Research Institute,undefined
[8] University of North Carolina at Chapel Hill,undefined
[9] GeneCast Biotechnology Co.,undefined
[10] Ltd,undefined
[11] The University of Texas MD Anderson Cancer Center,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Combining whole exome sequencing, transcriptome profiling, and T cell repertoire analysis, we investigate the spatial features of surgically-removed biopsies from multiple loci in tumor masses of 15 patients with non-small cell lung cancer (NSCLC). This revealed that the immune microenvironment has high spatial heterogeneity such that intratumoral regional variation is as large as inter-personal variation. While the local total mutational burden (TMB) is associated with local T-cell clonal expansion, local anti-tumor cytotoxicity does not directly correlate with neoantigen abundance. Together, these findings caution against that immunological signatures can be predicted solely from TMB or microenvironmental analysis from a single locus biopsy.
引用
收藏
相关论文
共 50 条
  • [41] Expression of Immune Cell Markers in Non-Small Cell Lung Cancer
    Wan, Haitao
    Zhang, Yuping
    Sui, Yingzhong
    Han, Shuhong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 142 - 142
  • [42] Molecular heterogeneity of osteopontin isoforms in non-small cell lung cancer
    Donington, Jessica
    Goparaju, Chandra
    Blasberg, Justin
    Harrington, Ryan
    Hirsch, Nathalie
    Pass, Harvey
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S250 - S251
  • [43] Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer
    Yang, Xiao-Rong
    Pi, Can
    Zhang, Yi-Chen
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Zhu, Dong-Qin
    Yang, Ling-Ling
    Yin, Jiani C. C.
    Deng, Jia-Yi
    Yang, Ming-Yi
    Luo, Wei-Chi
    Wu, Yi-Long
    Zhou, Qing
    MOLECULAR CARCINOGENESIS, 2023, 62 (07) : 1001 - 1008
  • [44] A novel murine model for interrogating immune response to tumor heterogeneity in non-small cell lung cancer
    Oh, Michael
    Abascal, Jensen W.
    Tran, Linh M.
    Salehi-Rad, Ramin
    Lim, Raymond J.
    Dumitras, Camelia
    Yean, Cara
    Xiao, Sunny
    Kahangi, Bitta P.
    Crosson, William P.
    Reyes, Edgar Perez
    Coleman, Nalani
    Rennels, Austin K.
    Krysan, Kostyantyn
    Liu, Bin
    Dubinett, Steven M.
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [45] Functional Heterogeneity of Osteopontin Isoforms in Non-small Cell Lung Cancer
    Goparaju, Chandra M. V.
    Pass, Harvey I.
    Blasberg, Justin D.
    Hirsch, Nathalie
    Donington, Jessica S.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1516 - 1523
  • [46] Tumor Heterogeneity and the Immune Response in Non-Small Cell Lung Cancer: Emerging Insights and Implications for Immunotherapy
    Oh, Michael S.
    Abascal, Jensen
    Rennels, Austin K.
    Salehi-Rad, Ramin
    Dubinett, Steven M.
    Liu, Bin
    CANCERS, 2025, 17 (06)
  • [47] Tumor heterogeneity, hypoxia and immune markers in patients with non-small cell lung cancer candidate to surgery
    Lopci, E.
    Toschi, L.
    Marchesi, F.
    Rahal, D.
    Castino, G.
    Cortese, N.
    Marchetti, S.
    Finocchiaro, G.
    Rossi, S.
    Allavena, P.
    Grizzi, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S672 - S672
  • [48] The Role of Intratumor Heterogeneity in the Response of Metastatic Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors
    Nicos, Marcin
    Krawczyk, Pawel
    Crosetto, Nicola
    Milanowski, Janusz
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Persistence of smoking mutational signatures in the non-small cell lung cancer genome
    Lindsay, Colin R.
    Nicola, Pantelis
    Gruber, Andreas
    Brown, Kate
    Carter, Mathew
    Adderley, Helen
    Rafee, Shereen
    Moss, Anna
    Wallace, Andrew
    Burghel, George
    Schlecht, Helene
    Baker, Katie
    Moghadam, Sharzad
    Rogan, Jane
    Weaver, Jamie
    Malliri, Angeliki
    Newman, William
    Blackhall, Fiona
    Wedge, David
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Mutational status of non-small cell lung cancer in Portugal: A multicentric study
    Duarte, J. A.
    Silva, D. N.
    Mendes, J. L.
    Ferreira, R. Q.
    Montenegro, M. A.
    Vicente, R. S.
    Mendes, A. Duarte
    Freitas, R. R.
    Martins, T. S.
    Silva, B. M.
    Machete, M.
    Fortuna, A. R.
    das Neves, R. Correia
    Correia, J.
    Simoes, P.
    Moreira-Pinto, J.
    Timoteo, T.
    Passos-Coelho, J. L. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1141 - S1141